The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug
“Switch”研究方案：一项随机对照试验，旨在评估在初始TNF抑制剂治疗失败的类风湿性关节炎患者中，改用另一种肿瘤坏死因子（TNF）抑制剂药物、阿巴西普或利妥昔单抗的疗效。
期刊:BMC Musculoskeletal Disorders
影响因子:2.4
doi:10.1186/1471-2474-15-452
Navarro Coy, Nuria C; Brown, Sarah; Bosworth, Ailsa; Davies, Claire T; Emery, Paul; Everett, Colin C; Fernandez, Catherine; Gray, Janine C; Hartley, Suzanne; Hulme, Claire; Keenan, Anne-Maree; McCabe, Christopher; Redmond, Anthony; Reynolds, Catherine; Scott, David; Sharples, Linda D; Pavitt, Sue; Buch, Maya H
